Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

NCT04275245 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Disease 2019 (COVID-19)

Interventions

DRUG: Meplazumab for Injection

Sponsor

Tang-Du Hospital